APO RESEARCH · REPORT
Neurovascular Devices
Neurovascular Devices refer to the tools that used to pass through the blood vessels to diagnose and treat diseases and conditions of the brain and nervous system rather than using open surgery. Neurovascular Devices comprise a large segment of medical devices, including embolic coils, neurovascular stents (carotid and intracranial stents), intravascular devices, neurothrombectomy devices, flow diverters, embolic protection device, balloons and stent retrievers.
Product & engineering
Understand the product.
Neurovascular Devices refer to the tools that used to pass through the blood vessels to diagnose and treat diseases and conditions of the brain and nervous system rather than using open surgery. Neurovascular Devices comprise a large segment of medical devices, including embolic coils, neurovascular stents (carotid and intracranial stents), intravascular devices, neurothrombectomy devices, flow diverters, embolic protection device, balloons and stent retrievers.
Selected research
Industry Research
Neurovascular Devices Industry Research Report 2026
Market perspective
Neurovascular Devices refer to the tools that used to pass through the blood vessels to diagnose and treat diseases and conditions of the brain and nervous system rather than using open surgery. Neurovascular Devices comprise a large segment of medical devices, including embolic coils, neurovascular stents (carotid and intracranial stents), intravascular devices, neurothrombectomy devices, flow diverters, embolic protection device, balloons and stent retrievers.
Top players in the neurovascular devices market are Stryker Corporation and Medtronic, Johnson & Johnson, Terumo Corporation, Penumbra, Abbott Laboratories, W. L. Gore & Associates, Microport Scientific Corporation and some others are also key players in this field.
Geographically, the neurovascular devices market is classified into North America, Europe, Japan, China and The Rest. North America dominates the global market, followed by Europe and Japan.
Read the full market overview
On the basis of product, the neurovascular devices market is classified into four major segments—aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems, support devices, and neurothrombectomy devices. The aneurysm coiling and embolization devices segment is the largest and accounts for about 37% of the global neurovascular devices market.
Neurovascular devices are widely used in hospitals, clinics and ambulatory surgical units.
Report Scope
This report quantifies the global Neurovascular Devices market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Neurovascular Devices Market by Company
Stryker Corporation
Johnson & Johnson
Medtronic
Terumo
Penumbra
Microport Scientific Corporation
Abbott Vascular
W. L. Gore & Associates
Neurovascular Devices Segment by Type
Aneurysm Coiling & Embolization Devices
Cerebral Balloon Angioplasty & Stenting Systems
Support Devices
Neurothrombectomy Devices
Neurovascular Devices Segment by Application
Hospitals
Clinics
Ambulatory Surgical Units
Neurovascular Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurovascular Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neurovascular Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurovascular Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Neurovascular Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Neurovascular Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Neurovascular Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Aneurysm Coiling & Embolization Devices
- Cerebral Balloon Angioplasty & Stenting Systems
- Support Devices
- Neurothrombectomy Devices
Applications
- Hospitals
- Clinics
- Ambulatory Surgical Units
Companies covered
- Stryker Corporation
- Johnson & Johnson
- Medtronic
- Terumo
- Penumbra
- Microport Scientific Corporation
- Abbott Vascular
- W. L. Gore & Associates
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Neurovascular Devices Market Size (2021-2032)
- 2.2.2 Global Neurovascular Devices Sales (2021-2032)
- 2.2.3 Global Neurovascular Devices Market Average Price (2021-2032)
- 2.3 Neurovascular Devices by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Aneurysm Coiling & Embolization Devices
- 2.3.3 Cerebral Balloon Angioplasty & Stenting Systems
- 2.3.4 Support Devices
- 2.3.5 Neurothrombectomy Devices
- 2.4 Neurovascular Devices by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Clinics
- 2.4.4 Ambulatory Surgical Units
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Neurovascular Devices Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Neurovascular Devices Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Neurovascular Devices Revenue of Manufacturers (2021-2026)
- 3.4 Global Neurovascular Devices Average Price by Manufacturers (2021-2026)
- 3.5 Global Neurovascular Devices Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Neurovascular Devices, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Neurovascular Devices, Product Type & Application
- 3.8 Global Manufacturers of Neurovascular Devices, Established Date
- 3.9 Global Neurovascular Devices Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Stryker Corporation
- 4.1.1 Stryker Corporation Company Information
- 4.1.2 Stryker Corporation Business Overview
- 4.1.3 Stryker Corporation Neurovascular Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Stryker Corporation Neurovascular Devices Product Portfolio
- 4.1.5 Stryker Corporation Recent Developments
- 4.2 Johnson & Johnson
- 4.2.1 Johnson & Johnson Company Information
- 4.2.2 Johnson & Johnson Business Overview
- 4.2.3 Johnson & Johnson Neurovascular Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Johnson & Johnson Neurovascular Devices Product Portfolio
- 4.2.5 Johnson & Johnson Recent Developments
- 4.3 Medtronic
- 4.3.1 Medtronic Company Information
- 4.3.2 Medtronic Business Overview
- 4.3.3 Medtronic Neurovascular Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Medtronic Neurovascular Devices Product Portfolio
- 4.3.5 Medtronic Recent Developments
- 4.4 Terumo
- 4.4.1 Terumo Company Information
- 4.4.2 Terumo Business Overview
- 4.4.3 Terumo Neurovascular Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Terumo Neurovascular Devices Product Portfolio
- 4.4.5 Terumo Recent Developments
- 4.5 Penumbra
- 4.5.1 Penumbra Company Information
- 4.5.2 Penumbra Business Overview
- 4.5.3 Penumbra Neurovascular Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Penumbra Neurovascular Devices Product Portfolio
- 4.5.5 Penumbra Recent Developments
- 4.6 Microport Scientific Corporation
- 4.6.1 Microport Scientific Corporation Company Information
- 4.6.2 Microport Scientific Corporation Business Overview
- 4.6.3 Microport Scientific Corporation Neurovascular Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Microport Scientific Corporation Neurovascular Devices Product Portfolio
- 4.6.5 Microport Scientific Corporation Recent Developments
- 4.7 Abbott Vascular
- 4.7.1 Abbott Vascular Company Information
- 4.7.2 Abbott Vascular Business Overview
- 4.7.3 Abbott Vascular Neurovascular Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Abbott Vascular Neurovascular Devices Product Portfolio
- 4.7.5 Abbott Vascular Recent Developments
- 4.8 W. L. Gore & Associates
- 4.8.1 W. L. Gore & Associates Company Information
- 4.8.2 W. L. Gore & Associates Business Overview
- 4.8.3 W. L. Gore & Associates Neurovascular Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 W. L. Gore & Associates Neurovascular Devices Product Portfolio
- 4.8.5 W. L. Gore & Associates Recent Developments
5 Global Neurovascular Devices Market Scenario by Region
- 5.1 Global Neurovascular Devices Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Neurovascular Devices Sales by Region: 2021-2032
- 5.2.1 Global Neurovascular Devices Sales by Region: 2021-2026
- 5.2.2 Global Neurovascular Devices Sales by Region: 2027-2032
- 5.3 Global Neurovascular Devices Revenue by Region: 2021-2032
- 5.3.1 Global Neurovascular Devices Revenue by Region: 2021-2026
- 5.3.2 Global Neurovascular Devices Revenue by Region: 2027-2032
- 5.4 North America Neurovascular Devices Market Facts & Figures by Country
- 5.4.1 North America Neurovascular Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Neurovascular Devices Sales by Country (2021-2032)
- 5.4.3 North America Neurovascular Devices Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Neurovascular Devices Market Facts & Figures by Country
- 5.5.1 Europe Neurovascular Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Neurovascular Devices Sales by Country (2021-2032)
- 5.5.3 Europe Neurovascular Devices Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Neurovascular Devices Market Facts & Figures by Country
- 5.6.1 Asia Pacific Neurovascular Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Neurovascular Devices Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Neurovascular Devices Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Neurovascular Devices Market Facts & Figures by Country
- 5.7.1 South America Neurovascular Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Neurovascular Devices Sales by Country (2021-2032)
- 5.7.3 South America Neurovascular Devices Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Neurovascular Devices Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Neurovascular Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Neurovascular Devices Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Neurovascular Devices Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Neurovascular Devices Sales by Type (2021-2032)
- 6.1.1 Global Neurovascular Devices Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Neurovascular Devices Sales Market Share by Type (2021-2032)
- 6.2 Global Neurovascular Devices Revenue by Type (2021-2032)
- 6.2.1 Global Neurovascular Devices Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Neurovascular Devices Revenue Market Share by Type (2021-2032)
- 6.3 Global Neurovascular Devices Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Neurovascular Devices Sales by Application (2021-2032)
- 7.1.1 Global Neurovascular Devices Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Neurovascular Devices Sales Market Share by Application (2021-2032)
- 7.2 Global Neurovascular Devices Revenue by Application (2021-2032)
- 7.2.1 Global Neurovascular Devices Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Neurovascular Devices Revenue Market Share by Application (2021-2032)
- 7.3 Global Neurovascular Devices Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Neurovascular Devices Value Chain Analysis
- 8.1.1 Neurovascular Devices Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Neurovascular Devices Production Mode & Process
- 8.2 Neurovascular Devices Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Neurovascular Devices Distributors
- 8.2.3 Neurovascular Devices Customers
9 Global Neurovascular Devices Analyzing Market Dynamics
- 9.1 Neurovascular Devices Industry Trends
- 9.2 Neurovascular Devices Industry Drivers
- 9.3 Neurovascular Devices Industry Opportunities and Challenges
- 9.4 Neurovascular Devices Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst